Placing an sirna order that produces an interpretable result: why off target effects make a single sequence uninterpretable however good the sirna knockdown looks, what the sirna vs aso choice actually turns on in compartment, chemistry and duration, which controls separate a phenotype caused by loss of the target from a phenotype caused by the reagent, how delivery decides everything in primary cells, and what to measure and when so that knockdown and phenotype are read at the right times
Silencing an transcript is easy; attributing a phenotype to that silencing is not. Every sequence has off target activity, delivery reagents have effects of their own, and the timing between knockdown and phenotype is rarely considered. The controls that make the result interpretable cost more than the reagents and are routinely omitted.
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
- the labelling clause behind research use only on a reagent
- 809.10(c)
- the biosafety manual that decides containment for transfection work
- BMBL
The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Designing the experiment
- Order several independent sequences. Two or preferably three non overlapping sequences against the same target, used separately. A phenotype seen with one sequence and not the others is an off target effect, and only independent sequences can distinguish the two.
- Include the controls that actually control something. A non targeting sequence matched for chemistry and concentration, a delivery only condition, and where possible a rescue with a resistant version of the target. The rescue is the strongest evidence available and the least often done.
- Choose the modality by compartment and duration. Short interfering duplexes act in the cytoplasm and are transient. Antisense chemistry reaches nuclear species and can work without a delivery reagent in some settings. The target's location and the required duration decide which.
- Solve delivery before optimising sequence. In hard to transfect and primary cells, delivery efficiency dominates outcome. Establish delivery with a labelled control and a well characterised positive sequence before concluding anything about your target.
- Measure knockdown at the protein, and time it properly. Transcript reduction is not protein reduction, and a long lived protein can persist well past the transcript. Measure the protein, and choose the phenotype timepoint from the protein curve rather than from convention.
- Use the lowest effective concentration. Off target effects scale with concentration. Titrate to the lowest dose that gives adequate knockdown rather than using a default, and report the concentration with the result.
Off target activity is the default, not the exception
Every silencing sequence has partial complementarity to other transcripts, and some of those interactions produce phenotypes. This is not a flaw in a particular reagent; it is a property of the technique, and the experimental design has to account for it.
The design that accounts for it is independent sequences plus a rescue. Anything less produces a result that a careful reader will discount, and rightly.
Timing is a design decision
Knockdown rises and falls over days, and the phenotype follows the protein rather than the transcript. Reading the phenotype at a fixed convenient timepoint frequently misses the window in which the protein was actually depleted.
Measure the protein over a time course once, then choose the phenotype timepoint from that curve and use it consistently. It is one extra experiment that makes every subsequent one interpretable.
Common questions
- How many sequences are enough?
- At least two independent ones, three if the phenotype is the main claim. Pools are convenient and can mask a single dominant off target effect, so where a conclusion rests on the result, individual sequences are more informative.
- Is a rescue experiment always necessary?
- For a claim that a phenotype is caused by loss of a specific target, it is the strongest evidence and increasingly expected. It is not always feasible, and where it is not, independent sequences and a dose response are the fallback.
- Why does knockdown work in a cell line and not in primary cells?
- Delivery, almost always. Primary cells are harder to transfect and more sensitive to the reagents, which is why electroporation, conjugated chemistries or viral expression are used there instead of lipid transfection.
- Transcript or protein for confirming knockdown?
- Protein, because that is what the phenotype depends on. Transcript measurement is a useful early check and can be misleading on its own when the protein is stable.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/sirna-order/.